First Ovarian Cancer Vaccine shows promise for potential eradication

Oxford University has announced significant progress in developing the world’s first ovarian cancer vaccine, named “OvarianVax.” If successful, the vaccine could dramatically reduce the risk of ovarian cancer.

According to a report by Sky News, the British Cancer Research Institute is supporting the project with a £600,000 budget.

This news is essential for women at high risk of ovarian cancer, particularly those carrying mutations in the BRCA tumor-suppressor gene.